These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 11336)
21. Short inhalation exposures of the isolated and perfused rat lung to respirable dry particle aerosols; the detailed pharmacokinetics of budesonide, formoterol, and terbutaline. Ewing P; Eirefelt SJ; Andersson P; Blomgren A; Ryrfeldt A; Gerde P J Aerosol Med Pulm Drug Deliv; 2008 Jun; 21(2):169-80. PubMed ID: 18518793 [TBL] [Abstract][Full Text] [Related]
22. Powder inhalation aerosol studies I: Selection of a suitable drug entity for bronchial delivery of new drugs. Chowhan ZT; Amaro AA J Pharm Sci; 1977 Sep; 66(9):1254-8. PubMed ID: 903861 [No Abstract] [Full Text] [Related]
24. Systemic absorption of selenious acid and elemental selenium aerosols in rats. Medinsky MA; Cuddihy RG; McClellan RO J Toxicol Environ Health; 1981; 8(5-6):917-28. PubMed ID: 7338952 [TBL] [Abstract][Full Text] [Related]
25. Pulmonary drug delivery by powder aerosols. Yang MY; Chan JG; Chan HK J Control Release; 2014 Nov; 193():228-40. PubMed ID: 24818765 [TBL] [Abstract][Full Text] [Related]
26. Absorption, distribution, and retention of inhaled selenious acid and selenium metal aerosols in beagle dogs. Weissman SH; Cuddihy RG; Medinsky MA Toxicol Appl Pharmacol; 1983 Mar; 67(3):331-7. PubMed ID: 6845362 [TBL] [Abstract][Full Text] [Related]
27. The lungs as a portal of entry for systemic drug delivery. Patton JS; Fishburn CS; Weers JG Proc Am Thorac Soc; 2004; 1(4):338-44. PubMed ID: 16113455 [TBL] [Abstract][Full Text] [Related]
28. Pulmonary availability of isotretinoin in rats after inhalation of a powder aerosol. Raleigh SM; Verschoyle RD; Bowskill C; Pastorino U; Staniforth JN; Steele F; Dinsdale D; Carthew P; Lim CK; Silvester J; Gescher A Br J Cancer; 2000 Oct; 83(7):935-40. PubMed ID: 10970697 [TBL] [Abstract][Full Text] [Related]
29. The particle has landed--characterizing the fate of inhaled pharmaceuticals. Patton JS; Brain JD; Davies LA; Fiegel J; Gumbleton M; Kim KJ; Sakagami M; Vanbever R; Ehrhardt C J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23 Suppl 2():S71-87. PubMed ID: 21133802 [TBL] [Abstract][Full Text] [Related]
30. Disposition and metabolism of [14C]dibenzo[c,g]carbazole aerosols in rats after inhalation. Bond JA; Ayres PH; Medinsky MA; Cheng YS; Hirshfield D; McClellan RO Fundam Appl Toxicol; 1986 Jul; 7(1):76-85. PubMed ID: 3732674 [TBL] [Abstract][Full Text] [Related]
31. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Sakagami M Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1030-60. PubMed ID: 17010473 [TBL] [Abstract][Full Text] [Related]
32. Inhaled insulin-intrapulmonary, intranasal, and other routes of administration: mechanisms of action. Henkin RI Nutrition; 2010 Jan; 26(1):33-9. PubMed ID: 20005465 [TBL] [Abstract][Full Text] [Related]
33. Solute absorption from the airways of the isolated rat lung. I. The use of absorption data to quantify drug dissolution or release in the respiratory tract. Niven RW; Byron PR Pharm Res; 1988 Sep; 5(9):574-9. PubMed ID: 3247320 [TBL] [Abstract][Full Text] [Related]
34. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290 [TBL] [Abstract][Full Text] [Related]
35. Delivery Technologies for Orally Inhaled Products: an Update. Moon C; Smyth HDC; Watts AB; Williams RO AAPS PharmSciTech; 2019 Feb; 20(3):117. PubMed ID: 30783904 [TBL] [Abstract][Full Text] [Related]
36. Drug delivery via the respiratory tract. Byron PR; Patton JS J Aerosol Med; 1994; 7(1):49-75. PubMed ID: 10147058 [TBL] [Abstract][Full Text] [Related]
37. The in vitro and in vivo investigation of a novel small chamber dry powder inhalation delivery system for preclinical dosing to rats. Sellers S; Horodnik W; House A; Wylie J; Mauser P; Donovan B Inhal Toxicol; 2015; 27(13):706-16. PubMed ID: 26452700 [TBL] [Abstract][Full Text] [Related]
38. Drug transport across pulmonary epithelial cell monolayers: effects of particle size, apical liquid volume, and deposition technique. Bur M; Huwer H; Muys L; Lehr CM J Aerosol Med Pulm Drug Deliv; 2010 Jun; 23(3):119-27. PubMed ID: 20073555 [TBL] [Abstract][Full Text] [Related]
39. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability. He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310 [TBL] [Abstract][Full Text] [Related]
40. Miniaturized nebulization catheters: a new approach for delivery of defined aerosol doses to the rat lung. Tronde A; Baran G; Eirefelt S; Lennernäs H; Bengtsson UH J Aerosol Med; 2002; 15(3):283-96. PubMed ID: 12396416 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]